Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.47 +0.07 (+1.59%)
As of 03:28 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.22 billion
P/E Ratio
23.53
Consensus Rating
Strong Buy
Volume
5,020 shares
Average Volume
81,251 shares
Today's Range
$4.39
$4.48
atai Life Sciences stock logo

2. atai Life Sciences NASDAQ:ATAI

$4.39 +0.42 (+10.58%)
Closing price 04:00 PM Eastern
Extended Trading
$4.38 -0.01 (-0.25%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$940.94 million
P/E Ratio
-6.36
Consensus Rating
Buy
Consensus Price Target
$11.25 (+156.3% Upside)
Volume
6.96 million shares
Average Volume
3.69 million shares
TuHURA Biosciences stock logo

3. TuHURA Biosciences NASDAQ:HURA

$2.91 -0.07 (-2.35%)
Closing price 04:00 PM Eastern
Extended Trading
$2.91 +0.00 (+0.03%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$145.65 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+335.3% Upside)
Volume
196,273 shares
Average Volume
306,668 shares
Today's Range
$2.89
$2.98
Ultrapar Participacoes stock logo

4. Ultrapar Participacoes NYSE:UGP

$3.28 -0.01 (-0.15%)
Closing price 03:59 PM Eastern
Extended Trading
$3.28 -0.01 (-0.15%)
As of 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar Participacoes

Market Capitalization
$3.66 billion
P/E Ratio
7.30
Consensus Rating
Buy
Consensus Price Target
$3.20 (-2.6% Downside)
Volume
724,514 shares
Average Volume
1.87 million shares
OS Therapies stock logo

5. OS Therapies NYSE:OSTX

$2.40 +0.21 (+9.59%)
Closing price 04:00 PM Eastern
Extended Trading
$2.48 +0.08 (+3.33%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$75.90 million
P/E Ratio
-2.79
Consensus Rating
Buy
Consensus Price Target
$18.00 (+650.0% Upside)
Volume
1.80 million shares
Average Volume
735,318 shares
Climb Bio stock logo

6. Climb Bio NASDAQ:CLYM

$2.19 -0.06 (-2.67%)
As of 04:00 PM Eastern

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb Bio

Market Capitalization
$148.39 million
P/E Ratio
-3.13
Consensus Rating
Buy
Consensus Price Target
$9.00 (+311.0% Upside)
Volume
640,116 shares
Average Volume
346,004 shares
Western Copper & Gold stock logo

7. Western Copper & Gold NYSE:WRN

$1.27 +0.03 (+2.42%)
As of 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$254.70 million
P/E Ratio
-63.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+215.0% Upside)
Volume
192,312 shares
Average Volume
373,463 shares
Quince Therapeutics stock logo

8. Quince Therapeutics NASDAQ:QNCX

$1.61 -0.02 (-1.23%)
Closing price 04:00 PM Eastern
Extended Trading
$1.62 +0.01 (+0.62%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$86.47 million
P/E Ratio
-1.48
Consensus Rating
Buy
Consensus Price Target
$8.14 (+405.8% Upside)
Volume
61,949 shares
Average Volume
235,266 shares
Immunic stock logo

9. Immunic NASDAQ:IMUX

$0.94 +0.02 (+2.71%)
Closing price 04:00 PM Eastern
Extended Trading
$0.94 -0.01 (-1.05%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$93.21 million
P/E Ratio
-0.77
Consensus Rating
Buy
Consensus Price Target
$7.50 (+693.7% Upside)
Volume
838,164 shares
Average Volume
1.24 million shares
MannKind stock logo

10. MannKind NASDAQ:MNKD

$3.94 -0.03 (-0.76%)
Closing price 04:00 PM Eastern
Extended Trading
$3.97 +0.03 (+0.76%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKind

Market Capitalization
$1.21 billion
P/E Ratio
35.82
Consensus Rating
Buy
Consensus Price Target
$9.71 (+146.6% Upside)
Volume
1.62 million shares
Average Volume
2.38 million shares
Hochschild Mining stock logo

11. Hochschild Mining OTCMKTS:HCHDF

$4.07 +0.14 (+3.56%)
As of 03:53 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$2.09 billion
Consensus Rating
Buy
Volume
3,710 shares
Average Volume
31,293 shares
Today's Range
$3.96
$4.16
50-Day Range
$3.26
$4.09
TriSalus Life Sciences stock logo

12. TriSalus Life Sciences NASDAQ:TLSI

$4.96 -0.16 (-3.13%)
Closing price 04:00 PM Eastern
Extended Trading
$4.97 +0.01 (+0.20%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$187.69 million
P/E Ratio
-4.20
Consensus Rating
Buy
Consensus Price Target
$10.75 (+116.7% Upside)
Volume
84,326 shares
Average Volume
63,181 shares
Rezolve AI stock logo

13. Rezolve AI NASDAQ:RZLV

$3.00 -0.03 (-0.99%)
Closing price 04:00 PM Eastern
Extended Trading
$3.01 +0.01 (+0.27%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$624.78 million
Consensus Rating
Buy
Consensus Price Target
$6.36 (+111.9% Upside)
Volume
5.10 million shares
Average Volume
6.98 million shares
Today's Range
$2.95
$3.08
Denison Mine stock logo

14. Denison Mine NYSEAMERICAN:DNN

$1.95 +0.03 (+1.56%)
Closing price 04:10 PM Eastern
Extended Trading
$1.96 +0.01 (+0.26%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$1.75 billion
P/E Ratio
-32.50
Consensus Rating
Buy
Consensus Price Target
$3.00 (+53.8% Upside)
Volume
31.93 million shares
Average Volume
78.30 million shares
FibroBiologics stock logo

15. FibroBiologics NASDAQ:FBLG

$0.59 +0.02 (+3.32%)
Closing price 04:00 PM Eastern
Extended Trading
$0.60 +0.01 (+2.39%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$24.67 million
P/E Ratio
-1.64
Consensus Rating
Buy
Consensus Price Target
$13.00 (+2,107.5% Upside)
Volume
306,513 shares
Average Volume
339,233 shares
ImmunityBio stock logo

16. ImmunityBio NASDAQ:IBRX

$2.24 -0.02 (-0.88%)
Closing price 04:00 PM Eastern
Extended Trading
$2.26 +0.02 (+0.89%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.12 billion
P/E Ratio
-4.67
Consensus Rating
Buy
Consensus Price Target
$10.75 (+379.9% Upside)
Volume
5.67 million shares
Average Volume
7.87 million shares
Genelux stock logo

17. Genelux NASDAQ:GNLX

$3.44 +0.08 (+2.38%)
Closing price 04:00 PM Eastern
Extended Trading
$3.44 +0.00 (+0.15%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. More about Genelux

Market Capitalization
$129.93 million
P/E Ratio
-4.00
Consensus Rating
Buy
Consensus Price Target
$17.75 (+416.0% Upside)
Volume
72,049 shares
Average Volume
180,222 shares
Stardust Power stock logo

18. Stardust Power NASDAQ:SDST

$0.38 -0.01 (-1.41%)
Closing price 04:00 PM Eastern
Extended Trading
$0.39 +0.00 (+1.17%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$23.38 million
P/E Ratio
-0.69
Consensus Rating
Buy
Consensus Price Target
$5.11 (+1,229.6% Upside)
Volume
609,578 shares
Average Volume
4.40 million shares
Mereo BioPharma Group stock logo

19. Mereo BioPharma Group NASDAQ:MREO

$1.65 +0.02 (+1.23%)
Closing price 04:00 PM Eastern
Extended Trading
$1.65 0.00 (0.00%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$262.35 million
P/E Ratio
-23.57
Consensus Rating
Buy
Consensus Price Target
$7.20 (+336.4% Upside)
Volume
512,499 shares
Average Volume
1.74 million shares
NRx Pharmaceuticals stock logo

20. NRx Pharmaceuticals NASDAQ:NRXP

$2.53 -0.09 (-3.44%)
Closing price 04:00 PM Eastern
Extended Trading
$2.56 +0.03 (+0.99%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx Pharmaceuticals

Market Capitalization
$50.12 million
P/E Ratio
-1.13
Consensus Rating
Buy
Consensus Price Target
$28.50 (+1,026.5% Upside)
Volume
237,998 shares
Average Volume
502,011 shares
zSpace stock logo

21. zSpace NASDAQ:ZSPC

$2.15 +0.01 (+0.47%)
As of 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$51.28 million
Consensus Rating
Buy
Consensus Price Target
$10.00 (+365.1% Upside)
Volume
69,365 shares
Average Volume
72,144 shares
Today's Range
$2.07
$2.22
FiscalNote stock logo

22. FiscalNote NYSE:NOTE

$0.50 +0.01 (+1.92%)
Closing price 03:59 PM Eastern
Extended Trading
$0.50 +0.00 (+0.20%)
As of 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FiscalNote Holdings, Inc operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. More about FiscalNote

Market Capitalization
$78.95 million
P/E Ratio
-1.56
Consensus Rating
Buy
Consensus Price Target
$2.44 (+388.5% Upside)
Volume
1.16 million shares
Average Volume
2.86 million shares
Ur Energy stock logo

23. Ur Energy NYSEAMERICAN:URG

$1.24 +0.06 (+5.08%)
Closing price 04:10 PM Eastern
Extended Trading
$1.25 +0.01 (+0.40%)
As of 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$452.39 million
P/E Ratio
-7.29
Consensus Rating
Buy
Consensus Price Target
$2.48 (+99.6% Upside)
Volume
3.40 million shares
Average Volume
5.33 million shares
United States Antimony stock logo

24. United States Antimony NYSE:UAMY

$4.54 +0.14 (+3.18%)
Closing price 04:00 PM Eastern
Extended Trading
$4.53 -0.01 (-0.33%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States Antimony

Market Capitalization
$548.08 million
P/E Ratio
-113.50
Consensus Rating
Buy
Consensus Price Target
$3.38 (-25.7% Downside)
Volume
5.01 million shares
Average Volume
3.96 million shares
Perspective Therapeutics stock logo

25. Perspective Therapeutics NYSE:CATX

$3.56 +0.18 (+5.33%)
Closing price 04:00 PM Eastern
Extended Trading
$3.56 0.00 (0.00%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$264.38 million
Consensus Rating
Buy
Consensus Price Target
$12.56 (+252.7% Upside)
Volume
485,276 shares
Average Volume
942,412 shares
Today's Range
$3.28
$3.57